We are live on ! Find out more
NRX

NEPHROGENEX INC COM
NRX

Delisted

NRX was delisted on the 10th of May, 2016.

Back to rankings

14 hedge funds and large institutions have $18.1M invested in NEPHROGENEX INC COM in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+14
Holders Change %
–
% of All Funds
0.4%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
14
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCP
Rho Capital Partners
New York
+$13.5M
2
VAM
Visium Asset Management
New York
+$4.86M
3
RCMB
Revelation Capital Management (Bermuda)
Bermuda
+$995K
4
KCM
Knoll Capital Management
Florida
+$510K
5
Bank of America
Bank of America
North Carolina
+$400K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCP
1
Rho Capital Partners
New York
$10.8M +$13.5M +1,326,826 New
VAM
2
Visium Asset Management
New York
$3.93M +$4.86M +476,491 New
LP
3
LMR Partners
United Kingdom
$1.22M +$1.53M +150,000 New
RCMB
4
Revelation Capital Management (Bermuda)
Bermuda
$792K +$995K +97,607 New
KCM
5
Knoll Capital Management
Florida
$412K +$510K +50,000 New
Bank of America
6
Bank of America
North Carolina
$319K +$400K +39,300 New
FWCM
7
First Western Capital Management
California
$194K +$244K +23,900 New
SIP
8
Stoneridge Investment Partners
Pennsylvania
$160K +$201K +19,700 New
FNYS
9
First New York Securities
New York
$159K +$199K +19,550 New
TMC
10
Trellus Management Company
Florida
$81K +$102K +10,000 New
TRCT
11
Tower Research Capital (TRC)
New York
$18K +$23K +2,255 New
Morgan Stanley
12
Morgan Stanley
New York
$7K +$8.3K +815 New
U
13
UBS
Switzerland
$2K +$2.4K +236 New
Citigroup
14
Citigroup
New York
$1K +$1.77K +174 New

NRX Hedge Fund Activity: Q1 2014 in Review

14 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in NEPHROGENEX INC COM (NRX) for Q1 2014, worth a combined $18.1M.

Buyers outnumbered sellers: 14 funds opened new NRX positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Rho Capital Partners, opening a new position worth an estimated $13.5M.

  • 14 institutional investors held NEPHROGENEX INC COM (NRX) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $18.1M of NEPHROGENEX INC COM stock for Q1 2014.
  • 14 funds opened new NEPHROGENEX INC COM positions in Q1 2014 and 0 closed out, a net change of +14 holders.
  • The largest NEPHROGENEX INC COM buyer in Q1 2014 was Rho Capital Partners, an estimated $13.5M added.

Based on aggregated 13F filings for Q1 2014.